Development and Progression of Renal Insufficiency With and Without Albuminuria in Adults With Type 1 Diabetes in the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications Study
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: This multicenter study examined the impact of albumin excretion rate (AER) on the course of estimated glomerular filtration rate (eGFR) and the incidence of sustained eGFR <60 ml/min/1.73 m2 in type 1 diabetes up to year 14 of the Epidemiology of Diabetes Interventions and Complications (EDIC) study (mean duration of 19 years in the Diabetes Control and Complications Trial [DCCT]/EDIC). RESEARCH DESIGN AND METHODS: Urinary albumin measurements from 4-h urine collections were obtained from participants annually during the DCCT and every other year during the EDIC study, and serum creatinine was measured annually in both the DCCT and EDIC study. GFR was estimated from serum creatinine using the abbreviated Modification of Diet in Renal Disease equation. RESULTS: A total of 89 of 1,439 subjects developed an eGFR <60 ml/min/1.73 m2 (stage 3 chronic kidney disease on two or more successive occasions (sustained) during the DCCT/EDIC study (cumulative incidence 11.4%). Of these, 20 (24%) had AER <30 mg/24 h at all prior evaluations, 14 (16%) had developed microalbuminuria (AER 30–300 mg/24 h) before they reached stage 3 chronic kidney disease, and 54 (61%) had macroalbuminuria (AER >300 mg/24 h) before they reached stage 3 chronic kidney disease. Macroalbuminuria is associated with a markedly increased rate of fall in eGFR (5.7%/year vs. 1.2%/year with AER <30 mg/24 h, P < 0.0001) and risk of eGFR <60 ml/min/1.73 m2 (adjusted hazard ratio 15.3, P < 0.0001), whereas microalbuminuria had weaker and less consistent effects on eGFR. CONCLUSIONS: Macroalbuminuria was a strong predictor of eGFR loss and risk of developing sustained eGFR <60 ml/min/1.73 m2. However, screening with AER alone would have missed 24% of cases of sustained impaired eGFR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Reduced eGFR without albuminuria has been frequently reported in type 1 and type 2 diabetes and is becoming more common over time as the prevalence of diabetes increases in the U.S. (2,3,16,(19)(20)(21).”
From 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2025 (2025) · cites this paper as [19]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Density Estimation for Statistics and Data Analysis
Silverman, B. W. (2018) · Routledge eBooks · doi:10.1201/9781315140919 · Cited by 15,796
Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079
Self-citationStandards of Medical Care in Diabetes
Power, D. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,673
Cox, D. R., & Oakes, D. (2018) · Chapman & Hall/CRC eBooks · doi:10.1201/9781315137438 · Cited by 6,234
Density Estimation for Statistics and Data Analysis
Dehnad, K. (1987) · Technometrics · doi:10.1080/00401706.1987.10488295 · Cited by 5,302
Fitzmaurice, G. M., Laird, N. M., & Ware, J. H. (2011) · Wiley Series in Probability and Statistics · doi:10.1002/9781119513469 · Cited by 4,639
Breslow, N., Cox, D. R., & Oakes, D. (1985) · Biometrics · doi:10.2307/2530888 · Cited by 4,333
Standards of Medical Care in Diabetes—2009
American Diabetes Association (2009) · Diabetes Care · doi:10.2337/dc09-s013 · Cited by 2,167
(2004) · Choice Reviews Online · doi:10.5860/choice.42-2265 · Cited by 1,384
Risk Factors for Renal Dysfunction in Type 2 Diabetes
Retnakaran, R., Cull, C. A., Thorne, K. I., Adler, A. I., Holman, R. R., & for the UKPDS Study Group (2006) · Diabetes · doi:10.2337/db05-1620 · Cited by 927
Self-citation
Cited by
Items 201–300 of 310
McGill, J. B., Wu, M., Pop‐Busui, R., Mizokami‐Stout, K., Tamborlane, W. V., Aleppo, G., Gubitosi‐Klug, R., Haller, M. J., Willi, S. M., Foster, N. C., et al. (2019) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2019.06.005 · Cited by 6
When ESKD complicates the management of diabetes mellitus
William, J. H., Morales, A., & Rosas, S. E. (2020) · Seminars in Dialysis · doi:10.1111/sdi.12873 · Cited by 6
Prakash, J., Patel, P. S., Iqbal, M., Sharma, S. S., Sharma, S., Agrawal, N. K., & Singh, U. (2022) · Journal of the Association of Physicians of India · doi:10.5005/japi-11001-0060 · Cited by 5
Quality of care of patients with type 1 diabetes: Population-based results in a French region
Penfornis, A., Personeni, E., Tiv, M., Monnier, C., Meillet, L., Combes, J., Mouret, C., & Picard, S. (2012) · Diabetes & Metabolism · doi:10.1016/j.diabet.2012.04.006 · Cited by 5
Gosai, S. A., Qadree, A. K., Singh, A. P., Chavan, M., & Oso, B. I. (2023) · Clinical Medicine And Health Research Journal · doi:10.18535/cmhrj.v3i3.170 · Cited by 4
Afşar, B., & Elsürer, R. (2012) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2012.05.016 · Cited by 5
on behalf of the AMD ANNALS Study Group, Mirijello, A., Viazzi, F. C., Fioretto, P., Giorda, C. B., Ceriello, A., Russo, G. T., Guida, P., Pontremoli, R., & Cosmo, S. D. (2018) · BMC Nephrology · doi:10.1186/s12882-018-1136-6 · Cited by 4
Managing chronic kidney disease in diabetes patients with the latest chemical therapies
Hu, J., & Du, Y. (2018) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2019.1552829 · Cited by 4
Keum, Y., Caramori, M. L., Cherney, D. Z. I., Crandall, J. P., de Boer, I. H., Lingvay, I., McGill, J. B., Polsky, S., Pop‐Busui, R., Rossing, P. R., et al. (2024) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.0000000000000567 · Cited by 4
Diabetic kidney disease: Is there a non-albuminuric phenotype in type 2 diabetic patients?
Laranjinha, I., Matias, P., Mateus, S., Aguiar, F. L., Pereira, P., Santos, M. P., Costa, R., Lourenço, A., Guia, J., Barata, J. D., et al. (2016) · Nefrología (English Edition) · doi:10.1016/j.nefroe.2016.09.003 · Cited by 4
Urinary lipid metabolites and progression of kidney disease in individuals with type 2 diabetes
Xiao, Y., Shi, C., Qin, S., He, A., Wu, X., Dai, C., & Zhou, Y. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1650498 · Cited by 3
Jaffa, M. A., Gebregziabher, M., & Jaffa, A. A. (2021) · Statistical Methods in Medical Research · doi:10.1177/09622802211060519 · Cited by 3
Horita, S., Watanabe, G., Misaka, S., Taira, S., Satoh, M., Maejima, Y., Shimomura, K., Shimabukuro, M., Kazama, J. J., & SHIGETOMI, S. (2024) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00180.2023 · Cited by 3
Wann sollte bei Patienten mit Diabetes mellitus eine Nierenbiopsie erfolgen?
Busch, M., & Wolf, G. (2015) · Der Nephrologe · doi:10.1007/s11560-014-0953-2 · Cited by 3
[Non-Classical Clinical Types and Pathological Changes of Diabetic Kidney Disease: A Review].
Fang, C., Sun, L., Liu, Y., Xiao, L., & Sun, L. (2023) · 四川大学学报:医学版 · doi:10.12182/20231160102 · Cited by 3
Rossing, P. R., & Flyvbjerg, A. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch44 · Cited by 3
Preventing kidney failure in people with diabetes
Marshall, S. M. (2014) · Diabetic Medicine · doi:10.1111/dme.12535 · Cited by 3
Overview of Diabetic Nephropathy
Mansour, I. S. M., & Thajudeen, B. (2016) · Springer eBooks · doi:10.1007/978-3-319-08873-0_1 · Cited by 3
Yamaguchi, S., Hamano, T., Oka, T., Doi, Y., Kajimoto, S., Sakaguchi, Y., Suzuki, A., & Isaka, Y. (2022) · PLoS ONE · doi:10.1371/journal.pone.0264568 · Cited by 3
(2012) · Kidney International Supplements · doi:10.1038/kisup.2012.62 · Cited by 3
Jiang, Q., Chen, H., Wang, K., Zhu, X., Yin, J., & Tang, W. (2025) · Non-coding RNA Research · doi:10.1016/j.ncrna.2025.05.003 · Cited by 2
Yu, M.-S., Chiu, C., Lo, F.-S., Lin, W.-C., Wu, L.-J., Yen, C.-Y., & Yu, M. (2025) · Metabolites · doi:10.3390/metabo15110734 · Cited by 2
Rajwadwala, Y., Patil, P., Chauhan, N., & Upadhyay, U. (2025) · Journal of Young Pharmacists · doi:10.5530/jyp.20250046 · Cited by 2
Porto, A. D., Candido, R., Manicardi, V., Rocca, A., Cosmo, S. D., Russo, G. T., & AMD Annals Study Group (2025) · Acta Diabetologica · doi:10.1007/s00592-025-02624-x · Cited by 2
Фенотипы диабетической болезни почек (обзор литературы и собственные данные)
Tsaryk, I., & Pashkovska, N. V. (2020) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.16.3.2020.205277 · Cited by 2
Sarafidis, P. A., & Bakris, G. L. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e32834e997f · Cited by 2
Treatment Goals in Diabetic Nephropathy
Vervoort, G. (2018) · Springer eBooks · doi:10.1007/978-3-319-93521-8_25 · Cited by 2
Caramori, M. L., & Rossing, P. R. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00054-8 · Cited by 4
Assessment of the Type 2 Diabetes Patient at Risk of Cardio-renal Complications
Lim, C. P. (2020) · The Singapore Family Physician · doi:10.33591/sfp.46.6.u1 · Cited by 1
PREVALENCE AND RISK FACTORS OF MICROALBUMINURIA IN TYPE 2 DIABETES MELLITUS
Abdulwahab, O., & Rasul, R. (2021) · Journal of Sulaimani Medical College · doi:10.17656/jsmc.10319 · Cited by 1
Dai, Q., Huang, S., Fang, Y., & Ding, X. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s467388 · Cited by 1
Balakumar, S., & Herath, C. (2026) · Indian Journal of Nephrology · doi:10.25259/ijn_125_2026 · Cited by 1
Genetic Risk Factors for Diabetic Nephropathy
Böger, C. A., & Mertens, P. R. (2012) · Wiley eBooks · doi:10.1002/9781118494073.ch3 · Cited by 1
Epidemiology of Chronic Kidney Disease in Diabetes
Icks, A., & Koch, M. (2012) · Wiley eBooks · doi:10.1002/9781118494073.ch2 · Cited by 2
Atypical Presentations of Diabetic Nephropathy and Novel Therapies
Imbriano, L. J., Maesaka, J. K., Mattana, J., Shirazian, S., & Jerums, G. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0793-9_8 · Cited by 1
de Borst, M. H., & Navis, G. J. (2015) · Diabetes Management · doi:10.2217/dmt.15.12 · Cited by 1
Chronic kidney disease related to diabetes in older patients
Sinay, I. R., & Inserra, F. (2017) · Wiley eBooks · doi:10.1002/9781118954621.ch8 · Cited by 1
Insulin Resistance and the Kidney in Youth
Bjornstad, P., & Cherney, D. Z. I. (2019) · Contemporary Endocrinology · doi:10.1007/978-3-030-25057-7_14 · Cited by 1
Putting it All Together: Practical Approach to the Patient with Diabetic Kidney Disease
Eng, E., & Quaggin, S. E. (2022) · Springer eBooks · doi:10.1007/978-3-030-86020-2_29 · Cited by 1
Natural Course (Stages/Evidence-Based Discussion)
Lovre, D., & Thethi, T. K. (2022) · Springer eBooks · doi:10.1007/978-3-030-86020-2_4 · Cited by 1
Screening, Early Diagnosis, Genetic Markers and Predictors of Progression
Tuazon, J. A., & Cho, J. (2022) · Springer eBooks · doi:10.1007/978-3-030-86020-2_8 · Cited by 1
Marshall, S. M., & Flyvbjerg, A. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch39 · Cited by 1
Sämann, A., & Wolf, G. (2013) · Der Nephrologe · doi:10.1007/s11560-013-0779-3 · Cited by 1
Diabetic Kidney Disease: Identification, Prevention, and Treatment
Caramori, M. L., & Rossing, P. R. (2022) · Springer eBooks · doi:10.1007/978-3-030-98927-9_7 · Cited by 1
A proteinúria é um preditor independente para progressão da doença renal do diabetes?
Brandão, S. C., de Freitas, S. B., Carvalho, L. M. R., Araújo, L. C., Guedes, J. V. M., de Oliveira, F. S., Silva, F. M. D. R. E., & Otoni, A. (2022) · Research Society and Development · doi:10.33448/rsd-v11i15.36895 · Cited by 1
Chronic Kidney Disease in Patients with Diabetes: Diabetic vs. Non-Diabetic Kidney Etiologies
Xu, G. (2022) · Journal of Diabetes Research Review & Reports · doi:10.47363/jdrr/2022(4)152 · Cited by 1
Diabetic Nephropathy in Type 1 Diabetes Mellitus
Rossing, P. R. (2022) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-031-13009-0_15 · Cited by 1
Kidney Disease and Diabetic Patients
Ministry of Health, S. A., Binjumaiah, S. Q. A., Abodabeel, A. H., Ministry of Health, S. A., Alotaibi, K. N., Ministry of Health, S. A., Alotaibi, B. M. G., Ministry of Health, S. A., Alenezi, K. R. A., Ministry of Health, S. A., et al. (2023) · International Journal of Medical Science and Clinical Research Studies · doi:10.47191/ijmscrs/v3-i11-74 · Cited by 1
Morfín, J. A., & Nizamic, T. J. (2024) · Springer eBooks · doi:10.1007/978-3-030-74720-6_56 · Cited by 3
La [b]maladie[/b] rénale diabétique : prise en charge actuelle et perspectives d’avenir
Krzesinski, J.-M., & Scheen, A. J. (2015) · JMIG · doi:10.53738/revmed.2015.11.483.1534 · Cited by 1
Standard and novel therapeutic approaches to diabetic nephropathy
Egido, J., Fernández‐Fernández, B., Ortíz, A., Mas, S., & Gómez‐Guerrero, C. (2015) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · Cited by 1
Penno, G., Russo, E., Garofolo, M., Daniele, G., Lucchesi, D., Giusti, L., Sancho, V., Bianchi, C., Dardano, A., Miccoli, R., et al. (2017) · Diabetologia · doi:10.1007/s00125-017-4387-z · Cited by 1
Diabetic Chronic Kidney Disease
MacIsaac, R. J., Jerums, G., & Watts, G. F. (2010) · Diabetes · doi:10.1002/9781118405550.ch2
Lithovius, R. (2015) · Työväentutkimus Vuosikirja
Experimental and genetic studies on podocyte molecules CD2AP and SHIP2 in diabetic nephropathy
Hyvönen, M. E. (2013) · Työväentutkimus Vuosikirja
Eighty years on insulin and ‘going strong’
White, R., Stirling, A., White, S., & Collier, A. (2014) · Practical Diabetes · doi:10.1002/pdi.1870
New approaches for the evaluation of renal vascular function in diabetes
Jerums, G., & MacIsaac, R. J. (2011) · Diabetologia · doi:10.1007/s00125-011-2225-2
Updates in the management of diabetic nephropathy
Prakash, J. (2015) · Clinical Queries Nephrology · doi:10.1016/j.cqn.2015.11.001
Vascular endothelial growth factor B-role in metabolism, lipotoxicity and disease
Mehlem, A. (2015) · Figshare
Proteome of Human Urinary Exosomes in Diabetic Nephropathy
Álvarez‐Llamas, G., & Zubiri, I. (2015) · Springer eBooks · doi:10.1007/978-94-007-7743-9_22-1
Some specificities in the management of hyperglycemia in patients with diabetic kidney disease
Dragovic, T., Marinkovic, D., Kikovic, S., Pejović, J., & Hajdukovic, Z. (2016) · Vojnosanitetski pregled · doi:10.2298/vsp150321008d
Har, R. L. H. (2014) · TSpace (University of Toronto)
Implications for the Mother with Diabetes
Wender-Ożegowska, E., & Sacks, D. A. (2017) · Wiley eBooks · doi:10.1002/9781119043805.ch27
Increased urinary albumin excretion in children with type 1 diabetes: is it a reason for concern?
Costacou, T. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.03.005
Jaffa, M. A., & Jaffa, A. A. (2018) · Communication in Statistics- Theory and Methods · doi:10.1080/03610926.2018.1473599
Sanogo, S., Konan, S. D., Yao, K. H., Kouassi, E., Diopoh, S. P., Aka, J. A., Niava, R., & Ankotché, A. (2018) · Journal of Nephropharmacology · doi:10.15171/npj.2018.21
LA MALATTIA RENALE CRONICA NON-ALBUMINURICA NEL DIABETE MELLITO TIPO 1
Garofolo, M., Daniele, G., & Penno, G. (2019) · il Diabete · doi:10.30682/ildia1904a
Samimagham, H. R., Tamaddondar, M., & Jahromi, M. K. (2021) · DOAJ (DOAJ: Directory of Open Access Journals) · doi:10.22062/jkmu.2021.91565
Enriquecimento da HDL em apolipoproteína A-IV favorece sua funcionalidade na doença renal diabética
Santana, M. D. F. M. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2020.tde-10022021-101317
A Paixón e a Semana Santa en Galicia: coñecemento do medio cultural galego
Gómez, F. S. L. (2002) · Dialnet (Universidad de la Rioja)
Imai, E. (2011) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.13370015.14742116
Doppler, K., Hammes, H., Heidenreich, A., Luft, D., Reiners, K., Risse, A., Schleicher, E., Sommer, C., Stratmann, B., Tschöpe, C., et al. (2014) · Springer eBooks · doi:10.1007/978-3-642-41358-2_8 · Cited by 1
Arterial stiffness and pulsatile hemodynamics in diabetes and obesity
Cohen, J. B., Prenner, S. B., & Chirinos, J. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91391-1.00030-3
Prevention and management of cardiovascular disease in kidney disease and kidney failure
Garimella, P. S., Weiner, D. E., & Sarnak, M. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818540-7.00020-3
Association Between Interlukin 10 Gene Polymorphism And Susceptibility To Diabetic Kidney Disease
elshamy, A., Elshafae, M., Eissa, H., Elfallah, A. A., & Abdel-Aziz, S. H. (2020) · Benha Medical Journal · doi:10.21608/bmfj.2020.70685
Sämann, A., & Wolf, G. (2013) · Humanmedizin kompakt · doi:10.1007/s40355-012-0006-x
FRCP, D. L. M. (2017) · Wiley eBooks · doi:10.1002/9781119052210.ch4
Proteome of Human Urinary Exosomes in Diabetic Nephropathy
Álvarez‐Llamas, G., & Zubiri, I. (2016) · Springer eBooks · doi:10.1007/978-94-007-7699-9_22
Approach to Chronic Kidney Disease in the Diabetic Patient
Afshinnia, F., & Brosius, F. C. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815876-0.00051-6
An Update of the Diagnosis for Diabetic Kidney Disease (Preprint)Preprint
Xu, G., & Wang, Q. (2020) · doi:10.2196/preprints.18045
(2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.107
Activation of renal dopaminergic system in early diabetic nephropathyPreprint
Horita, S., Watanabe, G., Misaka, S., Taira, S., Satoh, M., Maejima, Y., Shimomura, K., Kazama, J. J., & SHIGETOMI, S. (2022) · Research Square · doi:10.21203/rs.3.rs-1939167/v1
Potential biomarkers for early diagnosis of nephrotic changes in type 2 diabetic patients
Gopi, K., Nigoskar, S., Vaitla, P., & Kumar, V. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6ns5.11254
Garzaro, J. R. R., Godoy, J. J. G., & Fuentes, Á. P. (2022) · Revista de la Facultad de Medicina · doi:10.37345/23045329.v1i33.88 · Cited by 2
Yu, M., Lo, F., & Chou, Y.-H. (2023) · Research Square · doi:10.21203/rs.3.rs-3196132/v1
Morfín, J. A., & Nizamic, T. J. (2023) · Springer eBooks · doi:10.1007/978-3-030-01782-8_56-1
Saha, N. K. (2023) · Student s Journal of Health Research Africa · doi:10.51168/sjhrafrica.v4i12.900
Torres, K. E. R., Caiza, N. B. J., Fernández, J. C. T., Noboa, P. A. R., Proaño, M. A. C., Espinoza, M. X. R., Aguilar, A. A. P., Acosta, S. A. C., Barrera, K. S. C., Salgado, P. R. G., et al. (2024) · doi:10.56470/978-9942-660-75-6
Wolle, A. M., Tsegaye, G. W., & Azene, A. G. (2024) · Research Square · doi:10.21203/rs.3.rs-5318799/v1
Markham‐Lee, Z., Bhagat‐Jones, S., Carlton, J., Frankel, A., Fraser, S., Habte‐Asres, H. H., Hill, C., Kanumilli, N., Karalliedde, J. J., Maskell, A., et al. (2025) · Diabetic Medicine · doi:10.1111/dme.70013 · Cited by 2
Diabetic Kidney Disease: A Versatile Disease
Granados‐Silvestre, M. D. L. Á., Ortiz‐López, M. G., & Sanchez-Pozos, K. A. (2025) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815305692125010013
Awaludin, M., Putranto, R., Marbun, M. B. H., Yunir, E., Shatri, H., Wahyudi, E. R., & Pitoyo, C. W. (2025) · JMIR Biomedical Engineering · doi:10.2196/81454
Chronic Kidney Disease and Risk Management
(2025) · American Diabetes Association eBooks · doi:10.2337/9781580408462-ch18
Renal manifestations and diabetes mellitus: the missing link
Akpalu, J., Boima, V., & Abobi-Kanbigs, D. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33090-2.00009-6
Yu, Y., Lin, Q., Ye, D., Wang, Y., He, B., Li, Y., Huang, G., Zhou, Z., & Xiao, Y. (2020) · Figshare · doi:10.6084/m9.figshare.13142072
Doença Renal Diabética: nefropatia diabética e outras entidades
Miguel, I. R. (2021) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/4d9f-k097 · Cited by 1
Metadata
- Authors
- Molitch, M. E., Steffes, M., Sun, W., Rutledge, B., Cleary, P., de Boer, I. H., Zinman, B., Lachin, J., & for the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Group
- Affiliations
- Northwestern University (US)
- University of Minnesota (US)
- George Washington University (US)
- Weststat, Rockville, Maryland;
- University of Washington, Seattle, Washington;
- University of Toronto (CA)
- Corresponding author
- Cleary, Patricia
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2010-04-22
- Volume
- 33
- Issue
- 7
- Pages
- 1536-1543
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2890355
- OpenAlex
- W2112283107
- Semantic Scholar
- 28dfcf1a74005b6164f159cf1b64cfec2aecc582
- Cited by
- 306
- References
- 31
- Citations by year
- 2026: 6 · 2025: 10 · 2024: 15 · 2023: 13 · 2022: 25 · 2021: 19 · 2020: 17 · 2019: 25 · 2018: 23 · 2017: 17 · 2016: 17 · 2015: 24 · 2014: 33 · 2013: 23 · 2012: 22
- FWCI
- 15.28
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
- Keywords
- type 1 diabetes, albuminuria, macroalbuminuria, microalbuminuria, urinary albumin excretion rate, chronic kidney disease, estimated glomerular filtration rate decline, renal failure, diabetic nephropathy, Diabetes Control and Complications Trial, kidney disease screening, glycemic control, blood pressure control
- MeSH terms
- Adult, Albuminuria, Creatinine, Diabetes Mellitus, Type 1, Diabetic Nephropathies, Female, Follow-Up Studies, Glomerular Filtration Rate, Humans, Male, Predictive Value of Tests, Risk Factors, Severity of Illness Index, Multicenter Studies as Topic, Incidence, Randomized Controlled Trials as Topic, Disease Progression, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.